Duration of Using Proton Pump Inhibitors as a Risk Factor of Hepatic Encephalopathy in Patients with Cirrhosis

Q: How can I download an article?

To download an article from SID, first log in to the site, search for the article title, and click on the 'Download Article' option.

Q: How can I download an ISI article?

To download an ISI article on SID, enter the keyword or article title in the search bar, view the relevant results, click on the desired article, and select the 'Download Article' option.

Q: How can I access the SID database?

To access the SID database, visit SID.ir, create an account, and log in to access scientific resources.

Q: Is downloading articles from SID free?

Some articles on SID are available for free, while others require payment. Details are specified on the article's page.

ALLAMEH SEYED FARSHAD; Fakhrabadi Amir Akbar; Abbasi Najmeh; PEIMAN SOHEIL

مرکز اطلاعات علمی Scientific Information Database (SID) - Trusted Source for Research and Academic Resources

Journal Paper

Paper Information

Journal: GOVARESH JOURNAL Year:2018 | Volume:23 | Issue:1 Page(s): 22-25

Download Full-Text

View:

154

Download:

Cites:

Information Journal Paper

Title

Duration of Using Proton Pump Inhibitors as a Risk Factor of Hepatic Encephalopathy in Patients with Cirrhosis

Author(s)

ALLAMEH SEYED FARSHAD | Fakhrabadi Amir Akbar | Abbasi Najmeh | PEIMAN SOHEIL | Issue Writer Certificate

Keywords

Proton pump inhibitors

Hepatic Encephalopathy

Cirrhosis

Abstract

Background: In patients with Cirrhosis use of Proton pump inhibitors (PPIs) may increase the risk of infection including spontaneous bacterial peritonitis. Also, in some studies PPIs usage had significant relationship with the severity of Cirrhosis and development of hepatocellular carcinoma. In recent studies the relationship between PPIs usage and Hepatic Encephalopathy had been considered. The aim of this study was to assess the relationship between PPIs and Hepatic Encephalopathy for investigating their effects in the treatment of patients with Cirrhosis. Materials and Methods: In this study, 61 patients with liver Cirrhosis were evaluated. The patients were followed up in two groups: patients with Hepatic Encephalopathy and patients with other complications. Results: PPIs usage and also the type and dosage of these drugs were not statistically different between the two groups. The duration of PPIs usage in the patients with Hepatic Encephalopathy was 23 ± 5. 72 months and in the second group was 13. 04 ± 3. 061 months (p = 0. 039). Conclusion: In patients with Cirrhosis, PPIs consumption for a long period, increases the risk of Hepatic Encephalopathy.

Cites

No record.

References

No record.

Cite

APA: Copy

ALLAMEH, SEYED FARSHAD, Fakhrabadi, Amir Akbar, Abbasi, Najmeh, & PEIMAN, SOHEIL. (2018). Duration of Using Proton Pump Inhibitors as a Risk Factor of Hepatic Encephalopathy in Patients with Cirrhosis. GOVARESH JOURNAL, 23(1 ), 22-25. SID. https://sid.ir/paper/735881/en

Vancouver: Copy

ALLAMEH SEYED FARSHAD, Fakhrabadi Amir Akbar, Abbasi Najmeh, PEIMAN SOHEIL. Duration of Using Proton Pump Inhibitors as a Risk Factor of Hepatic Encephalopathy in Patients with Cirrhosis. GOVARESH JOURNAL[Internet]. 2018;23(1 ):22-25. Available from: https://sid.ir/paper/735881/en

IEEE: Copy

SEYED FARSHAD ALLAMEH, Amir Akbar Fakhrabadi, Najmeh Abbasi, and SOHEIL PEIMAN, “Duration of Using Proton Pump Inhibitors as a Risk Factor of Hepatic Encephalopathy in Patients with Cirrhosis,” GOVARESH JOURNAL, vol. 23, no. 1 , pp. 22–25, 2018, [Online]. Available: https://sid.ir/paper/735881/en

Related Journal Papers

No record.

Related Seminar Papers

No record.

Related Plans

No record.

Recommended Workshops